Type 2 Diabetes Care Beyond Blood Sugar: The 2026 ADA/EASD Report
The new ADA/EASD report puts heart, kidney, weight and everyday wellbeing alongside glucose. What patients...
TRUE METRIX Glucose Meter Safety Alert: What Users Should Check
TRUE METRIX safety alert guide covering E-5 error risk, affected systems, FDA Class I recall...
Tirzepatide Maintenance Study: What SURMOUNT-MAINTAIN Means
Plain-language SURMOUNT-MAINTAIN summary covering continued tirzepatide, dose reduction, weight regain, study limits, and patient questions...
Time-Restricted Eating vs Dietitian Guidance: What a 12-Month Diabetes-Risk Trial Found
A 12-month randomized trial compared time-restricted eating with personalized dietitian guidance in adults at risk...
The Unseen Epidemic: Unpacking Global Diabetes Statistics
The Unseen Epidemic: Unpacking Global Diabetes Statistics: evidence-based guidance reviewed against current NICE and ADA...
Synedica Peptide Alert: TGA Finds Unreliable Vial Contents
TGA testing found missing ingredients and inconsistent retatrutide in Synedica products. Read the affected names...
Stem Cell Research and Type 1 Diabetes: Hope, Limits, and Safety
Stem cell and islet research for type 1 diabetes is moving fast, but it is...
Semaglutide FLOW Kidney and Heart Findings: What Patients Should Know
A new FLOW analysis reports that semaglutide kidney and all-cause death benefits were consistent across...
Semaglutide and Bone Fracture Risk: What People With Type 2 Diabetes Should Know
An ENDO 2026 real-world study linked semaglutide with fewer bone fractures than several other weight-loss...